Direct-acting antivirals for hepatitis C do not increase the risk of hepatocellular carcinoma recurrence after locoregional therapy or liver transplant waitlist dropout

2017 ◽  
Vol 66 (1) ◽  
pp. S97 ◽  
Author(s):  
A.C. Huang ◽  
N. Mehta ◽  
J.L. Dodge ◽  
F.Y. Yao ◽  
N.A. Terrault
2018 ◽  
Vol 30 (4) ◽  
pp. 368-375 ◽  
Author(s):  
Xavier Adhoute ◽  
Guillaume Penaranda ◽  
Jean Luc Raoul ◽  
Floriane Sellier ◽  
Paul Castellani ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document